Question: is nektar therapeutics a good buy?
Answer: Valuation metrics show that Nektar Therapeutics may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of NKTR, demonstrate its potential to underperform the market. It currently has a Growth Score of F.